Plexon And Triangle BioSystems Announce Agreement To Market World's First VLSI, High-Channel Count Headset For Neuroscience Research
DALLAS, and RESEARCH TRIANGLE PARK, N.C., Nov. 4 /PRNewswire/ -- Plexon Inc., a global provider of neuroengineering research systems, today announced an agreement with Triangle BioSystems, Inc. (TBSI), to market the world's first VLSI integrated circuit, high-channel-count neural headset. The headset is about the size of a U.S. Dime, measuring 3mm x 14 mm x 20 mm, and is used to amplify and filter signals received from electrodes implanted in the brain and nervous system.
Under the terms of the exclusive agreement, Plexon will market the headsets designed by Triangle BioSystems as part of its extensive product line of neuroscience data acquisition hardware and analysis software. The new product will also be showcased at Plexon's booth (#834-836) at the 33rd Annual Meeting of the Society for Neuroscience in New Orleans November 9-12.
"The new VLSI headsets are smaller and lighter than any other commercial units," said Harvey Wiggins, President of Plexon. "This agreement expands our product offerings to include higher density and higher channel count instrumentation."
The introduction of the VLSI, high-channel count headset, which is available with 16 or 32 analog channels, enables neuroscientists to record from very high-density microelectrode arrays. An additional feature of the headset is bandpass filtering that allows researchers to isolate the neural signals being studied.
About Plexon
Plexon Inc. is a leading provider of innovative data acquisition hardware and software for recording and analyzing signals from the brain and nervous system. Based in Dallas, Texas, the privately-held company supplies instrumentation for basic brain and nervous system communication research, neural biosensors for drug and environmental screening, and interface devices for the growing neurotechnology industry. Plexon's current customers include over 250 domestic and international academic research labs and hospitals, pharmaceutical companies and military labs. For more information about the company and its products, call 214-369-4957 or visit http://www.plexoninc.com/.
About Triangle BioSystems
Triangle BioSystems, Inc. (TBSI), based in Research Triangle Park, North Carolina, develops, markets and supports biomedical analog signal processing products that significantly advance the research and performance capabilities of its commercial and academic customers in the neural recording marketplace. Proprietary miniaturized sub-assemblies are optimized through the utilization of a full custom ASIC design flow. TBSI product development is spearheaded by Dr. James Morizio, President and Founder, with 19 years of integrated circuit (IC) research, design, and development experience. For more information about TBSI, call 919-361-2663 or visit http://www.tbsi.biz/.
Contact: Susan Vaughan Plexon Inc. Phone: 214-369-4957 Email: susan@plexoninc.com Stephen Makgill Triangle BioSystems, Inc. Phone: 919-361-2663 or 919-302-5262 (cell) Email: smakgill@tbsi.biz
Plexon Inc.CONTACT: Susan Vaughan of Plexon Inc., +1-214-369-4957,susan@plexoninc.com; or Stephen Makgill of Triangle BioSystems, Inc.,+1-919-361-2663, or cell, +1-919-302-5262, smakgill@tbsi.biz